You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 23, 2024

CLINICAL TRIALS PROFILE FOR MANNITOL; SORBITOL


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for MANNITOL; SORBITOL

Trial ID Title Status Sponsor Phase Start Date Summary
NCT03636971 ↗ Gait Analysis Following Knee Viscosupplementation Completed Brigitte Jolles, MD Phase 2/Phase 3 2013-05-01 This is a pilot, double-blind, randomised trial that investigates which gait parameters are more sensitive following a single bolus injection of hyaluronic acid with mannitol, hyaluronic acid with sorbitol, or saline placebo for knee osteoarthritis. Outcome measures are gait analysis through a inertial sensors (Physilog), Knee Society Score (KSS), University of California Los Angeles (UCLA) activity-scale and EuroQol 5Dimensions. Follow-up will be of 4 weeks.
NCT03747679 ↗ Palatability (Taste) of Oral Formulations of Bosutinib Completed Pfizer Phase 1 2018-11-22 Healthy Adult Volunteer Taste Study of Oral Formulations of Bosutinib for Pediatric Use. This will be a single-blind, randomized, multiple-period (dosing over 4 days) study in healthy male and/or female participants. Approximately 8 participants will assess the sensory attributes of different powder for oral suspension (POS) formulations.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for MANNITOL; SORBITOL

Condition Name

Condition Name for MANNITOL; SORBITOL
Intervention Trials
CML 1
Gait 1
Injection 1
Knee Osteoarthritis 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for MANNITOL; SORBITOL
Intervention Trials
Osteoarthritis, Knee 1
Osteoarthritis 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for MANNITOL; SORBITOL

Trials by Country

Trials by Country for MANNITOL; SORBITOL
Location Trials
Switzerland 1
Belgium 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for MANNITOL; SORBITOL

Clinical Trial Phase

Clinical Trial Phase for MANNITOL; SORBITOL
Clinical Trial Phase Trials
Phase 2/Phase 3 1
Phase 1 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for MANNITOL; SORBITOL
Clinical Trial Phase Trials
Completed 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for MANNITOL; SORBITOL

Sponsor Name

Sponsor Name for MANNITOL; SORBITOL
Sponsor Trials
Brigitte Jolles, MD 1
Pfizer 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for MANNITOL; SORBITOL
Sponsor Trials
Other 1
Industry 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.